Valley Medical Group News

Valley’s Cancer Program Accredited with Commendation at Highest Level


RIDGEWOOD, NJ, NOVEMBER 1, 2015 — The Commission on Cancer of the American College of Surgeons has once again awarded a Three-Year Accreditation with Commendation Gold Level to the Cancer Program at The Valley Hospital.
Commission on Cancer of the American College of Surgeons

This level of recognition, one of the highest awarded by the Commission of Cancer, only occurs when a program meets or exceeds in 34 areas monitored by the commission, including measures related to clinical trials, prevention, and early detection. To earn the gold level, facilities must earn seven standard commendations. Accreditation by the Commission on Cancer is only given to facilities that voluntarily commit to providing the highest level of quality of cancer care through a patient-centered, multidisciplinary approach. Only 30 percent of hospitals in the U.S. and Puerto Rico are CoC-accredited.

“This level of approval is a testament to the continued commitment to excellence demonstrated by all the members of our Oncology team,” said Robert Korst, M.D., Medical Director of Valley’s Blumenthal Cancer Center.

Patients who receive care at an approved cancer program can be assured that they will have access to comprehensive care, state-of-the-art technology, and a multidisciplinary team approach to coordinate the best treatment options. They will receive information about ongoing clinical trials and have access to up to date disease specific cancer education, supportive services, and lifelong patient follow-up.

To maintain accreditation, facilities must undergo an on-site review every three years. The Commission on Cancer is a consortium of professional organizations that strives to improve patient outcomes.